ow. It’s Friday. This week was particularly interminable, wasn’t it? This is Meghana, by the way, subbing in for Ed by way of The Readout. (Sign up here!) As we ready ourselves for the glorious weekend, here’s a roundup of some notable pharma news:

Chinese scientists have used CRISPR to correct genetic mutations in a human embryo, New Scientist reports. Though the study focused on just six human embryos, it’s showing that CRISPR seems to work better in normal embryos than it did in previous tests on abnormal embryos that couldn’t develop into children. In related news, US scientists have made some major strides in synthetically assembling a complete yeast genome, STAT’s Sharon Begley reports.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.